Loading clinical trials...
Loading clinical trials...
Type I interferonopathies are rare autoinflammatory disorders caused by genetic defects and associated with significant morbidity and mortality. These diseases are refractory to conventional immunosup...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Imagine Institute
NCT06672237 · Neuromuscular Disease, Neuromuscular Diseases (NMD), and more
NCT05645003 · Spinal Cord Injuries, Neuropathic Pain, and more
NCT04806620 · Post-Acute COVID-19 Syndrome, ME/CFS, and more
NCT06235580 · Genetic Diseases, Immune Dysfunction, and more
NCT06555965 · Genetic Disease, STXBP1 Encephalopathy With Epilepsy, and more
Medical University Innsbruck
Innsbruck
Antwerp University Hospital
Antwerp
Children's Hospital Zagreb
Zagreb
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions